CG Oncology: CG Oncology, Inc. (CGON) Surges 25.0%: Is This an Indication of Further Gains?
CG Oncology, Inc. (CGON) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Read full article »
CG Oncology is a California-based clinical-stage biopharmaceutical company that researches and develops immunotherapies for the treatment of bladder cancer.
Read more